Breastfeeding and childhood cancer by 
The identification of leukaemia and lymphoma viruses in various
animal species (Gross, 1951; Vogt and Ishizaki, 1965) prompted the
search for viral causes of human leukaemia and lymphoma. The
Epstein Barr virus has been associated with Burkitt’s lymphoma in
children (Epstein et al, 1964) and the human T-cell leukaemia virus
with a rare form of adult leukaemia/lymphoma (Poiesz et al, 1980)
but, as yet, no specific infectious agent has been associated with the
majority of human leukaemias or lymphomas. Recently, attention
has focused on the association between surrogate markers of expo-
sure to infectious agents and the risk of childhood leukaemia
(Greaves and Alexander, 1993; Kinlen, 1995). 
Breastfed infants are at a reduced risk of gastrointestinal and
respiratory infections (WHO Collaborative Study Team on the
Role of Breastfeeding on the Prevention of Infant Mortality,
2000), but are also at an increased risk of mother-to-child trans-
mission of certain infectious agents (Ruff, 1994; Nduati et al,
2000). Several case-control studies of children with leukaemia
have reported a significantly reduced risk associated with having
been breastfed as infants (Shu et al, 1999; Smulevich et al, 1999;
Infante-Rivard et al, 2000; Bener et al, 2001), although not all
studies have noted such a relationship (van Steensel-Moll et al,
1986; McKinney et al, 1987; Davis et al, 1988; Magnani et al,
1988; Shu et al, 1995; Petridou et al, 1997; Dockerty et al, 1999;
Schüz et al, 1999; Rosenbaum et al, 2000; Hardell and Dreifaldt,
2001). Others have reported a significantly reduced risk of
Hodgkin’s disease (Grufferman et al, 1998) and non-Hodgkin’s
lymphoma (Bener et al, 2001) in breastfed children. 
We report here the results of an analysis of breastfeeding
patterns in infancy among children with leukaemia and other
cancers and among control children in the UK Childhood Cancer
Study (UK Childhood Cancer Study Investigators, 2000). An a
priori hypothesis was that any association with breastfeeding
should be seen for childhood leukaemia, and possibly for child-
hood lymphoma, but not for other childhood cancers. 
MATERIALS AND METHODS 
Subjects 
The UKCCS is a national population-based case-control study.
Details of the study design are given elsewhere (UK Childhood
Cancer Study Investigators, 2000). Briefly, children aged 0–14 with
cancer diagnosed in England and Wales (1992–96) and Scotland
(1991–94) were eligible for inclusion in the study. Detailed diag-
nostic review information was obtained from multiple sources,
including histopathology reviews and clinical trial data. Subtyping
of leukaemia was made possible by collecting together and
reviewing cytogenetic and molecular details (UK Childhood Cancer
Study Investigators, 2000). For each case, two controls were
randomly selected from Family Health Services Authorities (in
England and Wales) and Health Boards (in Scotland) matched to the
case by month and year of birth, sex and region of residence at diag-
nosis. Eligible controls who did not participate in the study were
replaced by another matched control until, where possible, two
controls had been enrolled for each participating case. Participation
rates were 87% for cases and 72% for first-choice controls. 
The mothers of 3838 cases and 7629 controls were interviewed,
using a standard questionnaire, that included questions about social,
medical and behavioural factors. Included among the questions to the
mothers were ‘Did you ever breastfeed (the child)? How old was (the
child) when you gave your last breast feed? Did you ever use formula
milk? If so, how old was (the child) when he/she had his/her first
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bank?’ Responses to these questions are examined in this report. 
Analysis 
A total of 943 children aged under 12 months at diagnosis/pseudodi-
agnosis were excluded from the analyses to prevent the introduction
of possible biases if breastfeeding were to cease prematurely in
children aged under 12 months with cancer. A further 60 children
were excluded because information about breastfeeding had not been
provided by their biological mother. Overall 338 cases and 665
controls were excluded leaving 3500 cases and 6964 controls – 91%
of all interviewed and potentially eligible subjects. 
Analyses were carried out for all cancers combined (3500
cases), and separately for leukaemia (1637 cases), Hodgkin’s
disease (114 cases), non-Hodgkin’s lymphoma (228 cases) and all
other cancers (1521 cases). For certain analyses children with
leukaemia were subdivided into those with acute lymphoblastic
leukaemia (ALL, 1401 cases) and acute myeloid leukaemia
(AML, 214 cases). Those with ALL were subclassified further, as
having common ALL (cALL, 879 cases), T cell ALL (134 cases),
and those with B-lineage ALL were further subclassified as TEL-
AML 1 (95 cases) or hyperdiploidy (358 cases). 
Since the hypotheses concerning the role of infectious agents in
childhood cancer are chiefly concerned with leukaemia and
lymphoma, and because of the possible differential participation of
the parents of children with and without cancer and differential
recall of events in childhood, some analyses were restricted to
children with cancer. In these restricted analyses, the breastfeeding
histories of children with leukaemia or lymphoma were compared
with those of children with other cancers, i.e. taking the children
with other cancers as ‘controls’. 
Odds ratios (ORs) and their 95% confidence intervals (CIs)
were estimated using unconditional logistic regression (StataCorp,
1999) and adjusted for region (10 in total), sex, age at diagnosis (in
single years), birth order (1, 2, 3, 4+) and deprivation index (7
levels). For certain analyses, additional adjustments were
performed for the mother’s age at leaving school and at the time of
the child’s birth, child’s birthweight, whether or not the child had
been admitted to a special care baby unit, and had attended day
care in the first year of life, and maternal smoking when the child
was 1 year old. Trends were assessed using likelihood ratio tests. 
Results showing data from more than one study are presented in
the form of plots of odds ratios. Each odds ratio is plotted as a black
square, the area of which is proportional to the amount of statistical
information for that particular estimate, i.e. the reciprocal of the
variance of the log odds ratio, which reflects the reliability with
which the odds ratio is estimated. The corresponding 95% CIs are
shown as horizontal black lines. Where CIs are so narrow as to be
contained entirely in the black box, they are plotted as white lines.
Summary odds ratios are plotted in the form of a diamond, the width
of which indicates the corresponding 95% CIs, and the dotted
vertical line indicates the value of the summary odds ratio. 
RESULTS 
Table 1 shows the distribution of children with leukaemia, Hodgkin’s
disease, non-Hodgkin’s lymphoma, other cancers, all cancers and
controls, according to whether or not they were reported to have ever
been breastfed and the reported duration that they had been breastfed;
it also shows the corresponding adjusted odds ratios, with 95% confi-
dence intervals, and the results of tests for trend by duration of breast-
feeding. About two thirds of the children were reported to have been
breastfed, with almost one fifth for longer than 6 months. The
adjusted odds ratios associated with ever having been breastfed were
below 1.0 and of borderline statistical significance for leukaemia
(OR = 0.89, 95%CI 0.80–1.00,  P = 0.06) and for all cancers
combined (OR = 0.92, 95% CI 0.84–1.00, P= 0.05). For each cancer
type shown in Table 1, none of the trends with increasing duration of
breastfeeding was statistically significant. The odds ratios in Table 1
were not materially altered after additional adjustment for maternal
education, maternal age, birthweight, admission to a special care
baby unit, attendance at day care, or maternal smoking. 
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Table 1 Distribution of children with cancer and controls, according to cancer type and breastfeeding history, and the associated odds ratios* (ORs) and 95%
confidence intervals (CIs) 
Leukaemia  Hodgkin’s disease  Non-Hodgkin’s  Other cancers All cancers Controls 
n = 1637 n = 114 lymphoma  n = 1521 n = 3500 n = 6964
n = 228
a) Number (%) 
never breastfed 629 (38.4) 43 (37.7) 79 (34.7) 592 (38.9) 1343 (38.4) 2500 (35.9) 
ever breastfed 1008 (61.6) 71 (62.3) 149 (65.4) 929 (61.1) 2157 (61.6) 4464 (64.1) 
duration < 1 month 251 (15.3) 23 (20.2) 33 (14.5) 241 (15.8) 548 (15.7) 1015 (14.6) 
duration 1–6 months 454 (27.7) 29 (25.4) 75 (32.9) 389 (25.6) 947 (27.1) 2034 (29.2) 
duration ≥ 7 months 302 (18.5) 19 (16.7) 41 (18.0) 298 (19.6) 660 (18.9) 1410 (20.3) 
unknown 1 (0.1) –– 1 (0.1) 2 (0.1) 5 (0.1) 
b) ORs* (95% CIs) 
never breastfed (reference) 1.0 1.0 1.0 1.0 1.0 
ever breastfed 0.89 (0.80–1.00) 1.01 (0.67–1.53) 1.03 (0.77–1.38) 0.90 (0.80–1.02) 0.92 (0.84–1.00) 
duration < 1 month 0.96 (0.81–1.14) 1.50 (0.88–2.57) 1.04 (0.68–1.59) 1.01 (0.86–1.20) 1.01 (0.89–1.14) 
duration 1–6 months 0.88 (0.77–1.02) 0.85 (0.51–1.40) 1.12 (0.80–1.50) 0.83 (0.72–0.96) 0.88 (0.79–0.98) 
duration ≥ 7 months 0.85 (0.73–1.00) 0.90 (0.50–1.60) 0.90 (0.60–1.34) 0.93 (0.79–1.08) 0.89 (0.79–1.01) 
c) Test for trend 
with duration χ 1
2 = 1.11 χ 1
2 = 1.22 χ 1
2 = 1.07 χ 1
2 = 0.10 χ 1
2 = 1.50 
of breastfeeding+ P = 0.29 P = 0.27 P = 0.30 P = 0.75 P = 0.22 
*Adjusted by age at diagnosis, sex, region, birth order and deprivation index. +Excludes never breast fed and unknown duration categories, based on median
duration within each duration category (9 days, 91 days and 304 days) for the control population. Table 2 shows results, for various subtypes of leukaemia, for
children who had ever versus never been breastfed and according to
the reported duration of breastfeeding. The numbers in each cate-
gory are comparatively small and none of the odds ratios or tests for
trend with duration of breastfeeding was statistically significant.
The results for leukaemia were also examined separately for first
born children and the odds ratio associated with ever having been
breastfed in this subgroup was 0.98 (95% CI 0.82–1.18). 
Table 3 shows age-specific results according to whether or not
the children were breastfed, separately for children with
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Table 2 Distribution of children with leukaemia, according to the type of leukaemia and breastfeeding history, and the associated odds ratios* (ORs) and 95%
confidence intervals (CIs) 
Acute myeloid  Acute lymphoblastic 
Sub-categories of acute lymphoblastic leukaemia  leukaemia (AML)  leukaemia (ALL) 
n = 214 n = 1401
T cell ALL  Common ALL 
Sub-categories of B-lineage ALL  n = 134 n = 879
TEL-AML 1  Hyperdiploidy 
n = 95 n = 358 
a) Number (%) 
never breastfed 92 (43.0) 529 (37.8) 48 (35.8) 320 (36.4) 34 (35.8) 131 (36.6) 
ever breastfed 122 (57.0) 872 (62.2) 86 (64.2) 559 (63.6) 61 (64.2) 227 (63.4) 
duration < 1 month 29 (13.6) 217 (15.5) 15 (11.2) 149 (17.0) 13 (13.7) 64 (17.9) 
duration 1–6 months 61 (28.5) 388 (27.7) 43 (32.1) 243 (27.7) 23 (24.2) 100 (27.9) 
duration ≥ 7 months 32 (15.0) 266 (19.0) 28 (20.9) 167 (18.9) 25 (26.3) 63 (17.6) 
unknown – 1 (0.1) ––– –
b) ORs* (95% CIs) 
never breastfed (reference) 1.0 1.0 1.0 1.0 1.0 1.0 
ever breastfed 0.78 (0.58–1.05) 0.91 (0.81–1.04) 1.14 (0.78–1.66) 0.96 (0.82–1.11) 0.97 (0.62–1.50) 0.96 (0.76–1.22) 
duration < 1 month 0.82 (0.53–1.26) 0.98 (0.82–1.17) 0.86 (0.47–1.55) 1.09 (0.88–1.34) 0.87 (0.45–1.67) 1.14 (0.83–1.57) 
duration 1–6 months 0.85 (0.60–1.20) 0.90 (0.77–1.04) 1.27 (0.82–1.95) 0.91 (0.76–1.09) 0.80 (0.46–1.38) 0.93 (0.71–1.23) 
duration ≥ 7 months 0.65 (0.43–1.00) 0.89 (0.75–1.05) 1.20 (0.73–1.97) 0.92 (0.75–1.13) 1.31 (0.76–2.25) 0.87 (0.63–1.19) 
c) Test for trend 
with duration χ 1
2 = 1.46 χ 1
2 = 0.50 χ 1
2 = 0.29 χ 1
2 = 0.52 χ 1
2 = 2.72 χ 1
2 = 1.47 
of breastfeeding+ P = 0.23 P = 0.48 P = 0.59 P = 0.47 P = 0.10 P = 0.23 
*Adjusted by age at diagnosis, sex, region, birth order and deprivation index. +Excludes never breast fed and unknown duration categories, based on median
duration within each duration category (9 days, 91 days and 304 days) for the control population. 
Table 3 Age-specific distribution of children with cancer and controls, and associated odds ratios* (ORs) and 95% confidence intervals (CIs) 
Leukaemia Hodgkin’s Non-Hodgkin’s  Other cancers All cancers Controls 
disease lymphoma
Age 1 year 
a) Numbers (%) 
never breastfed 59 (44.0) – 2 (66.7) 67 (32.5) 128 (37.3) 261 (37.9) 
ever breastfed 75 (56.0) – 1 (33.3) 139 (67.5) 215 (67.7) 427 (62.1) 
b) ORs* (CIs) for ever 
vs never breastfed 0.76 (0.51–1.12) – 1.76 (0.09–35.9) 1.48 (1.04–2.09) 1.12 (0.84–1.48) 
c) P value (ever vs never) 0.17 – 0.71 0.03 0.44 
Ages 2–5 years 
a) Numbers (%) 
never breastfed 332 (37.3) 8 (53.3) 20 (30.8) 236 (42.9) 596 (39.2) 1088 (36.1) 
ever breastfed 558 (62.7) 7 (46.7) 45 (69.2) 314 (57.1) 924 (60.8) 1926 (63.9) 
b) ORs* (CIs) for ever 
vs never breastfed 0.95 (0.81–1.11) 0.57 (0.19–1.69) 1.24 (0.71–2.15) 0.75 (0.62–0.91) 0.88 (0.79–1.00) 
c) P value (ever vs never) 0.52 0.31 0.45 0.004 0.05 
Age 6+ years 
a) Numbers (%) 
never breastfed 238 (38.8) 35 (35.4) 57 (35.6) 289 (37.8) 619 (37.8) 1151 (35.3) 
ever breastfed 375 (61.2) 64 (64.7) 103 (64.4) 476 (62.2) 1018 (62.2) 2111 (64.7) 
b) ORs* (CIs) for ever 
vs never breastfed 0.85 (0.70–1.02) 1.12 (0.71–1.75) 0.99 (0.70–1.41) 0.92 (0.77–1.09) 0.91 (0.80–1.04) 
c) P value (ever vs never) 0.09 0.62 0.97 0.34 0.16 
*Adjusted by age of diagnosis, sex, region, birth order and deprivation index. leukaemia, Hodgkin’s disease, non-Hodgkin’s lymphoma, other
cancers, and all cancers combined. The divisions by age were
determined a priori, with the specific hypothesis that the effects of
any infectious agent would be greatest for cALL at ages 2–5
(Greaves and Alexander, 1993). For leukaemia the odds ratios did
not differ significantly from 1.0 at any age and there is no statis-
tical evidence that the results varied according to age at diagnosis.
Most children with leukaemia were diagnosed at ages 2–5 years
and in this age group the odds ratios for the various leukaemia
subtypes for ever having been breastfed versus never having been
breastfed were: 0.95 (0.80–1.12) for ALL; 0.95 (0.55–1.64) for
AML; 1.03 (0.83–1.25) for cALL; 1.18 (0.64–2.18) for T cell
ALL; 0.84 (0.50–1.40) for TEL-AML 1; and 1.03 (0.77–1.37) for
hyperdiploidy. Thus there was no strong evidence of heterogeneity
between the subtypes at those ages. Nor was there evidence that
the findings for the lymphomas varied by age, although there was
some evidence of heterogeneity in all other cancer categories.
Detailed examination for specific cancers within this category
revealed no consistent pattern. Of these, the most common cancers
before the age of 6 were tumours of the central nervous system (57
cases at age 1, OR = 1.79, 95% CI 0.94–3.41; and 210 cases at age
2–5, OR = 0.91, 95% CI 0.67–1.23) and renal tumours (39 cases at
age 1, OR = 1.85, 95% CI 0.85–4.02 and 99 cases at age 2–5, OR
= 0.68, 95% CI 0.44–1.04). Both these tumour types contributed to
the comparatively high odds ratio for children aged 1 and the
comparatively low odds ratio at ages 2–5, and these may well be
chance findings. 
Table 4 shows results according to whether or not the child was
ever given formula feed and, if so, the age the child was when such
feeds were introduced. No consistent pattern is evident, and no
results are statistically significant. Nor did the risk of childhood
cancer appear to be influenced by having been given expressed milk
from a milk bank. The results are, however, based on small numbers
(about 2% of children ever received milk from a milk bank), the
respective odds ratios were: 0.89 (0.57–1.39) for leukaemia; 1.50
(0.46–4.95) for Hodgkin’s disease; 1.17 (0.46–2.93) for non-
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Table 4 Distribution of children with cancer and controls, according to the type of cancer and age at introduction of first formula feed, and the associated odds
ratios* (ORs) and 95% confidence intervals (CIs) 
Leukaemia Hodgkin’s disease  Non-Hodgkin’s  Other cancers  All cancers  Controls 
n = 1637 n = 114 lymphoma  n = 1521 n = 3500 n = 6964 
n = 228
a) Number (%) 
no formula feeds 223 (13.6) 16 (14.0) 32 (14.0) 216 (14.2) 487 (13.9) 1047 (15.0) 
first use <1 month 1024 (62.6) 73 (64.0) 135 (59.2) 960 (63.1) 2192 (62.6) 4136 (59.4) 
first use ≥ 1 month 390 (23.8) 25 (21.9) 61 (26.8) 345 (22.7) 821 (23.5) 1778 (25.5) 
unknown –– –– – 3 (<0.1) 
b) ORs* (95% CIs) 
no formula feeds 1.0 1.0 1.0 1.0 1.0 
first use <1 month 1.11 (0.94–1.31) 1.28 (0.72–2.26) 1.22 (0.82–1.84) 1.09 (0.92–1.29) 1.11 (0.98–1.26) 
first use ≥ 1 month 0.98 (0.81–1.18) 1.11 (0.58–2.11) 1.30 (0.83–2.03) 0.93 (0.77–1.12) 0.98 (0.86–1.13) 
c) P value P = 0.44 P = 0.48 P = 0.27 P = 0.65 P = 0.28 
(ever vs never) 
*Adjusted by age at diagnosis, sex, region, birth order and deprivation index. 
Table 5 Distribution of children with cancer, according to cancer type and breastfeeding history, and the associated odds ratios*
(ORs) and 95% confidence intervals (CIs) for leukaemia and lymphoma compared to all other cancers 
Leukaemia Hodgkin’s Non-Hodgkin’s Other cancers 
n = 1637 disease  lymphoma n = 228 n = 1521 
n = 114
a) Number (%) 
never breastfed 629 (38.4) 43 (37.7) 79 (34.7) 592 (38.9) 
ever breastfed 1008 (61.6) 71 (62.3) 149 (65.4) 929 (61.1) 
duration < 1 month 251 (15.3) 23 (20.2) 33 (14.5) 241 (15.8) 
duration 1–6 month 454 (27.7) 29 (25.4) 75 (32.9) 389 (25.6) 
duration ≥ 7 months 302 (18.5) 19 (16.7) 41 (18.0) 298 (19.6) 
unknown 1 (0.1) ––1 (0.1) 
b) ORs* (95% CIs) 
never breastfed (reference) 1.0 1.0 1.0 
ever breastfed 1.00 (0.85–1.17) 1.24 (0.79–1.95) 1.26 (0.91–1.75) 
duration < 1 month 0.96 (0.77–1.19) 1.65 (0.92–2.98) 1.20 (0.75–1.90) 
duration 1–6 month 1.09 (0.90–1.31) 1.07 (0.62–1.86) 1.56 (1.07–2.28) 
duration ≥ 7 months 0.91 (0.74–1.13) 1.11 (0.59–2.10) 0.94 (0.60–1.47) 
c) Test for trend 
with duration χ 1
2 = 0.52 χ 1
2 = 0.82 χ 1
2 = 2.63 
of breastfeeding+ P = 0.47 P = 0.36 P = 0.11 
*Adjusted by age at diagnosis, sex, region, birth order and deprivation index, using as the control population children with other
cancers. +Excludes never breast fed and unknown duration categories, based on median duration within each duration category
(11 days, 106 days and 330 days) for the control population (children with other cancers). Hodgkin’s lymphoma; 1.03 (0.68–1.58) for other childhood
cancers; and 0.99 (0.72–1.36) for all cancers combined. 
When children with other cancers are taken as the comparison
group, the odds ratios associated with ever having been breastfed
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Figure 1 Odds ratio for childhood leukaemia by history of having been breastfed 
Cases/Controls 
Study Never Ever Odds ratio (95% Cl) for ever versus never 
van Steensel-Moll et al (1986) 195/198 321/302 1.10 (0.80− 1.40) 
McKinney et al (1987)a 85/264 78/235 1.02 (0.71− 1.47) 
Davis et al (1988)b 16/74 47/107 2.03 (1.08− 3.83) 
Magnani et al (1988)c,d 75/148 88/159 1.09 (0.75− 1.60) 
Shu et al (1995)c,d 38/43 121/116 1.17 (0.70− 1.90) 
Petridou et al (1997) 52/106 101/194 0.85 (0.52− 1.41) 
Dockerty et al (1999)c,e 8/34 89/269 0.98 (0.39− 2.47) 
Schüz et al (1999)c,d 439/409 562/592 0.88 (0.74− 1.06) 
Shu et al (1999)c,d 1126/1096 1074/1322 0.79 (0.70− 0.91) 
Smulevich et al (1999)c 40/55 159/343 0.64 (0.41− 1.00) 
Infante-Rivard et al (2000)e 282/239 209/252 0.68 (0.49− 0.95) 
Rosenbaum et al (2000)e,f 136/372 119/388 0.84 (0.63− 1.11) 
Bener et al (2001)c,e 37/22 32/47 0.35 (0.21− 0.62) 
Hardell et al (2001)c 30/31 205/206 0.90 (0.50− 1.60) 
UKCCS 629/2500 1008/4464 0.89 (0.80− 1.00) 
All studies 3188/5591 4213/8996 0.86 (0.81-0.92) 
Test for heterogeneity: χ 14=30.21; P < 0.01 
Odds ratio for childhood leukaemia by duration of breastfeeding compared to never breastfed 
Study Cases/Controls Odds ratio (95% Cl) versus never breastfed 
Duration ≤ 6 months
McKinney et al (1987)a 68/178 1.17 (0.80− 1.71) 
Davis et al (1988)b 20/43 2.15 (1.02− 4.55) 
Magnani et al (1988)c,d 73/131 1.10 (0.74− 1.64) 
Shu et al (1995)c,d 37/33 1.26 (0.70− 2.40) 
Dockerty et al (1999)c,e 47/123 1.24 (0.47− 3.23) 
Schüz et al (1999)c,d 416/417 0.93 (0.77− 1.13) 
Shu et al (1999)c,d 623/704 0.87 (0.75− 1.01) 
Smulevich et al (1999)c 92/167 0.76 (0.47− 1.22) 
Infante-Rivard et al (2000)e,g 104/125 0.68 (0.49− 0.95) 
Hardell et al (2001)c 128/124 0.90 (0.50− 1.70) 
UKCCS 705/3049 0.91 (0.80− 1.03) 
All studies 2313/5094 0.91 (0.85–0.99) 
Duration > 6 months
McKinney et al (1987)a 9/57 0.48 (0.23− 1.03) 
Davis et al (1988)b 27/64 1.95 (0.97− 3.91) 
Magnani et al (1988)c,d 15/28 1.06 (0.54− 2.08) 
Shu et al (1995)c,d 84/83 1.14 (0.70− 1.90) 
Dockerty et al (1999)c,e 40/146 0.62 (0.28− 1.38) 
Schüz et al (1999)c,d 146/175 0.78 (0.60− 1.01) 
Shu et al (1999)c,d 450/617 0.70 (0.59− 0.82) 
Smulevich et al (1999)c 67/176 0.52 (0.32− 0.86) 
Infante-Rivard et al (2000)e,g 105/127 0.67 (0.47− 0.94) 
Hardell et al (2001)c 77/82 0.90 (0.50− 1.70) 
UKCCS 302/1410 0.85 (0.73− 1.00) 
All studies 1322/2965 0.78 (0.71-0.85) 
Test for heterogeneity ≤ 6 months: χ 10
2 = 13.01; P > 0.1; NS 
Test for heterogeneity > 6 months: χ 10
2 = 17.92; P < 0.1 
Test for heterogeneity between short-term and long-term breastfeeding: χ 1
2 = 6.90; P < 0.01 
aData provided by McKinney (personal communication) 
bNumbers of cases and controls derived from data presented by the authors 
c"Never" includes breastfed for  <2 days (Dockerty et al 1999); < 1 month (Magnani et al 1988, Shu et al 1995, Schüz et al 1999, Shu et al 1999, Hardell et al
2001); < 2 months (Smulevich et al 1999); ≤ 6 months (Bener et al 2001) 
dAcute leukaemia only 
eAcute lymphatic leukaemia only 
fData from meeting abstract 
gDuration  ≤ 3 months and > 3 months
0.0 1.0 2.0 3.0
0.0 1.0 2.0 3.0
2are 1.00, 1.24 and 1.26, respectively for leukaemia, Hodgkin’s
disease and non-Hodgkin’s lymphoma (Table 5). 
The results from the UKCCS study with respect to breast-
feeding were compared with relevant results from other epidemio-
logical studies of childhood cancer (van Steensel-Moll et al, 1986;
McKinney et al, 1987; Davis et al, 1988; Hartley et al, 1988;
Magnani et al, 1988; Golding et al, 1990; Shu et al, 1995; Petridou
et al, 1997; Grufferman et al, 1998; Dockerty et al, 1999; Schüz
et al, 1999; Shu et al, 1999; Smulevich et al, 1999; Infante-Rivard
et al, 2000; Rosenbaum et al, 2000; Bener et al, 2001; Hardell and
Dreifaldt, 2001). The UKCCS results did not differ significantly
from those of previous studies, they have been combined with
these and the overall results are shown for leukaemia (Figure 1),
Hodgkin’s disease (Figure 2), non-Hodgkin’s lymphoma (Figure 3),
other childhood cancers (Figure 4) and all childhood cancers
combined (Figure 5). Not all studies published separate results for
each cancer type and so the totals for each type do not add up to
the ‘all cancer’ values. For childhood leukaemia, there is evidence
of a statistically significant reduction in the odds ratio associated
with ever having been breastfed (OR = 0.86, 95% CI 0.81–0.92)
and having been breastfed for more than 6 months (OR = 0.78,
95% CI 0.71–0.85). However, there is also evidence of a reduction
in the odds ratio of similar magnitude associated with ever having
been breastfed for Hodgkin’s disease (OR = 0.74, 95% CI
0.58–0.93), all non-haematological cancers (OR = 0.85, 95% CI
0.76–0.95) and for all childhood cancers combined (OR = 0.90,
95% CI 0.84–0.97). 
DISCUSSION 
Breastfeeding provides a range of immunological benefits to the
infant (Jelliffe and Jelliffe, 1978; Goldman, 1993; Cuthbertson, 1999;
WHO Collaborative Team on the Role of Breastfeeding on the
Prevention of Infant Mortality, 2000). In the first hours after birth,
breast milk contains anti-microbial immunoglobulins; subsequently it
also contains lymphocytes, macrophages and soluble factors, such as
cytokines, lactoferrin, lysozyme, complement components, that may
alter response to infection (Goldman, 1993; Hanson, 2000). However,
breastfeeding also predisposes to the transmission of various infec-
tious agents from mother to child (Ruff, 1994; Nduati et al, 2000). 
Greaves’ delayed exposure hypothesis predicts a protective
effect for protracted breastfeeding specifically for childhood acute
lymphoblastic leukaemia as a consequence of priming of the
developing immune system by both vertical transmission of infec-
tive agents and immunological properties of breast milk (Greaves,
1997). The results from the UKCCS provide, however, equivocal
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Figure 2   Odds ratio for childhood Hodgkin's disease by history of having been breastfed
Cases/Controls 
Study Never Ever Odds ratio (95% CI) for ever versus never 
Davis et al (1988)a 8/74 5/107 0.43 (0.14–1.31) 
Shu et al (1995)b 3/2 11/12 0.50 (0.10–5.50) 
Grufferman et al (1998)c 221/245 223/411 0.68  (0.50–0.94) 
Smulevich et al (1999)b 4/8 43/86 1.00 (0.30–3.30) 
Bener et al (2001)b 10/4 12/18 0.27 (0.07–1.01) 
Hardell et al (2001)b 7/6 21/24 0.50 (0.10–2.70) 
UKCCS 43/2500 71/4464 1.01 (0.67–1.53) 
All studies 296/2839 386/5122 0.74 (0.58–0.93)
Test for heterogeneity: χ 6
2 = 6.16; P > 0.1; NS 
Odds ratio for childhood Hodgkin’s disease by duration of breastfeeding compared to never breastfed
Study Cases/Controls O dds ratio (95% CI) versus never breastfed
Duration ≤ 6 months
Davis et al (1988)a 5/43 1.08 (0.35–3.35) 
Shu et al (1995)b 3/4 0.47 (0.00–5.80) 
Smulevich et al (1999)b 27/37 1.46 (0.42–5.03) 
Hardell et al (2001)b 13/14 0.60 (0.10–4.50) 
UKCCS 52/3049 1.06 (0.69–1.63) 
All studies 100/3147 1.06 (0.73–1.54)
Duration > 6 months
Davis et al (1988)a 0/64 0.00 (0.00–0.57) 
Shu et al (1995)b 8/8 0.57 (0.00–8.90) 
Smulevich et al (1999)b 16/49 0.65 (0.18–2.31) 
Hardell et al (2001)b 8/10 0.50 (0.10–2.80) 
UKCCS 19/1410 0.90 (0.51–1.62) 
All studies 51/1541 0.65 (0.40–1.06)
Test for heterogeneity ≤ 6 months: χ 4
2 = 0.80; P > 0.1; NS 
Test for heterogeneity > 6 months: χ 4
2 = 17.55; P < 0.01 
Test for heterogeneity between short-term and long-term breastfeeding: χ 1
2 = 2.44; P > 0.1; NS 
aNumbers of cases and controls derived from data presented by the authors 
b“Never” includes breastfed for < 1 month (Shu et al 1995, Hardell et al 2001); < 2 months (Smulevich et al 1999); ≤ 6 months (Bener et al 2001) 
cData from meeting abstract 
0.0 1.0 2.0 3.0
0.0 1.0 2.0 3.0support for the role of breastfeeding in the aetiology of childhood
leukaemia. Although there is weak evidence, of borderline statistical
significance, of a small reduction in the odds ratio for leukaemia in
children who were breastfed, a reduction in the odds ratio of a
similar magnitude was also found for all childhood cancers.
Furthermore, the combined results from all relevant published
studies suggest that, although having been breastfed is associated
with an apparent small reduction in the odds ratio for childhood
leukaemia (Figure 1), it is also associated with a small reduction in
the odds ratio for Hodgkin’s disease (Figure 2), non-haemato-
logical childhood cancers (Figure 4) and for all childhood cancers
combined (Figure 5). 
Information on breastfeeding practices were reported by
mothers at the time of interview. Although there are known inac-
curacies in such reporting (DHS Comparative Studies, 1999), it is
unknown whether this is biased between the mothers of cases and
controls. Studies comparing the duration of breastfeeding reported
by mothers with the duration that was recorded at the time when
their children were young indicate that women tend to round the
reported durations to the nearest 6 months (DHS Comparative
Studies, 1999). 
Furthermore, 8 years after the birth of a child there is an overall
tendency for women to report somewhat longer durations of breast-
feeding than had been recorded at the time when the child was young
(Vobecky et al, 1988). A review of the role of infant feeding in the
aetiology of childhood diabetes mellitus showed that in studies where
there was a substantially lower participation rate in controls than cases
there was a tendency for the odds ratio associated with ever having
been breastfed to be reduced (Norris and Scott, 1996). Participation in
the UKCCS was lower in controls than cases (UK Childhood Cancer
Study, 2000). Furthermore, participating controls were of higher
socio-economic status than the first choice controls eligible for this
study, but whether or not these factors produced bias is unknown. 
In conclusion, it is unclear whether the apparent small reduction
in the risk of each type of childhood cancer reported here is a non-
specific effect of breastfeeding on childhood cancer or whether it
reflects some systematic bias shared by the majority of the case-
control studies that have investigated aetiological factors in
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Figure 3 Odds ratio for childhood non-Hodgkin’s lymphoma by history of having been breastfed
Cases/Controls 
Study Never Ever Odds ratio (95% CI) for ever versus never 
McKinney et al (1987)a 16/264 9/235 0.56 (0.23–1.35) 
Davis et al (1988)b 5/74 8/107 1.11 (0.36–3.34) 
Magnani et al (1988)c 9/148 10/159 1.03 (0.42–2.55) 
Shu et al (1995)c 17/12 51/56 0.62 (0.30–1.50) 
Smulevich et al (1999)c 12/14 58/126 0.54 (0.24–1.21) 
Bener et al (2001)c 9/3 17/23 0.25 (0.06–0.99) 
Hardell et al (2001)c 3/12 49/36 5.50 (1.20–25.0) 
UKCCS 79/2500 149/4464 1.03 (0.77–1.38) 
All studies 150/3027 351/5206 0.90 (0.72–1.14)
Test for heterogeneity: χ 7
2 = 13.17; P < 0.1 
Odds ratio for childhood non-Hodgkin’s lymphoma by duration of breastfeeding compared to never breastfed
Study Cases/Controls Odds ratio (95% CI) versus never breastfed 
Duration ≤ 6 months
McKinney et al (1987)a 6/178 0.49 (0.18–1.32) 
Davis et al (1988)b 6/43 2.07 (0.63–6.78) 
Magnani et al (1988)c 10/131 1.26 (0.51–3.10) 
Shu et al (1995)c 12/12 0.66 (0.20–2.40) 
Smulevich et al (1999)c 29/63 0.54 (0.22–1.29) 
Hardell et al (2001)c 29/21 5.10 (1.10–24.0) 
UKCCS 108/3049 1.09 (0.80–1.48) 
All studies 200/3497 1.04 (0.81–1.34)
Duration > 6 months
McKinney et al (1987)a 2/57 0.60 (0.13–2.78) 
Davis et al (1988)b 2/64 0.46 (0.00–2.15) 
Magnani et al (1988)c 0/28 0.00 (0.00–2.33) 
Shu et al (1995)c 39/44 0.61 (0.30–1.50) 
Smulevich et al (1999)c 29/63 0.54 (0.22–1.29) 
Hardell et al (2001)c 20/15 7.00 (1.30–37.0) 
UKCCS 41/1410 0.89 (0.60–1.34) 
All studies 133/1681 0.78 (0.57–1.07)
Test for heterogeneity ≤ 6 months: χ 6
2 = 10.46; P > 0.1; NS 
Test for heterogeneity > 6 months: χ 6
2 = 18.64; P < 0.01 
Test for heterogeneity between short-term and long-term breastfeeding: χ 1
2 = 1.89; P > 0.1; NS 
aData provided by McKinney (personal communication) 
bNumbers of cases and controls derived from data presented by the authors 
c“Never” includes breastfed for < 1 months (Magnani et al 1988, Shu et al 1995, Hardell et al 2001); <2 months (Smulevich et al 1999); ≤ 6 months 
(Bener et al 2001) 
0.0 1.0 2.0 3.0
0.0 1.0 2.0 3.0childhood cancer. We are unable to decide which of these possibil-
ities is the more likely. 
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Figure 4 Odds ratio for all childhood cancers except leukaemia and lymphoma by history of having been breastfed
Cases/Controls 
Study Never Ever Odds ratio (95% CI) for ever versus never 
Davis et al (1988)a 66/74 46/107 0.48 (0.30–0.78) 
Smulevich et al (1999)b 49/78 228/471 0.77 (0.52–1.14) 
Hardell et al (2001)a,b 78/67 423/459 0.79 (0.56–1.12) 
UKCCS 592/2500 929/4464 0.90 (0.80–1.02) 
All studies 785/2719 1626/5501 0.85 (0.76–0.95)
Test for heterogeneity: χ 3
2 = 6.76; P < 0.1 
Odds ratio for all childhood cancers except leukaemia and lymphoma by duration of breastfeeding compared to never breastfed
Study Cases/Controls Odds ratio (95% CI) versus never breastfed 
Duration ≤ 6 months
Davis et al (1988)a 28/43 0.73 (0.41–1.30) 
Smulevich et al (1999)b 121/232 0.83 (0.55–1.26) 
Hardell et al (2001)a,b 239/273 0.75 (0.52–1.09) 
UKCCS 630/3049 0.89 (0.79–1.02) 
All studies 1018/3597 0.86 (0.77–0.97)
Duration > 6 months
Davis et al (1988)a 18/64 0.32 (0.17–0.58) 
Smulevich et al (1999)b 107/239 0.71 (0.47–1.09) 
Hardell et al (2001)a,b 184/186 0.85 (0.58–1.25) 
UKCCS 298/1410 0.93 (0.79–1.09) 
All studies 607/1899 0.85 (0.74–0.97)
Test for heterogeneity ≤ 6 months: χ 3
2 = 1.13; P > 0.1; NS 
Test for heterogeneity > 6 months: χ 3
2 = 11.64; P < 0.01 
Test for heterogeneity between short-term and long-term breastfeeding: χ 1
2 = 0.05; P > 0.1; NS 
aNumbers of cases and controls derived from data presented by the authors 
b“Never” includes breastfed for < 1 month (Hardell et al 2001); < 2 months (Smulevich et al 1999) 
0.0 1.0 2.0 3.0
0.0 1.0 2.0 3.0South West region; CED Chilvers and K Muir, Trent region; NT
Fear, G Law, J Simpson and E Roman, Leukaemia Research Fund
Data Management Processing Group. 
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